
Overview
Dr. Bailey received his M.D. and Ph.D. degrees from the Johns Hopkins University School of Medicine through the Medical Scientist Training Program and completed medical residency at the Massachusetts General Hospital. He subsequently completed fellowship training in Infectious Diseases at the Johns Hopkins University School of Medicine before transitioning to a faculty position. His primary clinical interests are management and treatment of HIV and viral hepatitis, including hepatitis c virus. His research interests include the study of human B cells and neutralizing antibody responses against hepatitis C virus (HCV), hepatitis B virus (HBV), SARS-CoV-2, and respiratory syncytial virus (RSV), with the goal of developing improved vaccines against these viruses.
Dr. Bailey is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Hepatitis C, Hepatitis, COVID-19, and HIV/AIDS.
His clinical research consists of co-authoring 64 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of COVID-19.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
1800 Orleans Street, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Bayview Medical Center
Dr. Werbel is a physician-scientist who provides consultative care for patients at Johns Hopkins who experience infectious disease complications before and after organ transplant, as well as in the setting of solid tumors or blood cancers. His research with the Johns Hopkins Transplant Research Center uses a combination of epidemiological and laboratory methods to better personalize the prevention of infectious complications among patients with complex immunodeficiencies. This includes using national cohort studies and clinical trials to optimize the use of vaccines and other prophylactic therapies for high-risk immunosuppressed populations. Dr. Werbel is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), HIV/AIDS, and Hepatitis.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Robin Avery is an infectious disease physician who joined the Johns Hopkins faculty in 2012, with two decades of experience in transplant infectious disease. She is a past chair of the American Society of Transplantation (AST) Infectious Disease Community of Practice, was a co-editor of the first edition of the AST ID Guidelines, and serves on a Guidelines Committee for the Infectious Disease Society of America (IDSA) on immunizations in the immunocompromised host. She was the founding head of the Transplant Infectious Disease Section at the Cleveland Clinic and served as the founding director of the Cleveland Clinic Transplant ID Special Fellowship, authoring a curriculum that served as the basis for curricula later endorsed by the AST and IDSA. Her clinical and research interests include pre-transplant donor and recipient evaluation, and prevention and treatment of post-transplant infections, particularly transplant-associated viruses, viral load monitoring, novel therapies for CMV, hypogammaglobulinemia, immunizations, and strategies for safer living post-transplant. She has a strong interest in patient education and co-authored the script for a video designed to educate patients on decreasing post-transplant infection risks. Dr. Avery is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Cytomegalic Inclusion Disease, Cytomegalovirus Infection, COVID-19, and Sepsis.
Kathleen Neuzil is an Infectious Disease provider in Baltimore, Maryland. Dr. Neuzil is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Typhoid Fever, Salmonella Enterocolitis, Flu, and COVID-19.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hepatitis CDr. Bailey isDistinguished. Learn about Hepatitis C.
- Advanced
- COVID-19Dr. Bailey isAdvanced. Learn about COVID-19.
- HepatitisDr. Bailey isAdvanced. Learn about Hepatitis.
- Experienced
- AIDS Dementia ComplexDr. Bailey isExperienced. Learn about AIDS Dementia Complex.
- AIDS Dysmorphic SyndromeDr. Bailey isExperienced. Learn about AIDS Dysmorphic Syndrome.
- HIV/AIDSDr. Bailey isExperienced. Learn about HIV/AIDS.
- Long Haul COVIDDr. Bailey isExperienced. Learn about Long Haul COVID.
- MyelitisDr. Bailey isExperienced. Learn about Myelitis.
- Severe Acute Respiratory Syndrome (SARS)


